Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Conformis Inc. CFMS

Conformis Inc is an us-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.


Recent & Breaking News (NDAQ:CFMS)

Conformis, Inc. Announces Exclusive Distribution Agreement in China

GlobeNewswire June 23, 2021

Conformis, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit

GlobeNewswire May 18, 2021

Conformis, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference

GlobeNewswire May 12, 2021

Conformis, Inc. Announces 510(k) Clearance for Identity Imprint(TM) Knee Replacement System

GlobeNewswire May 10, 2021

Conformis Reports First Quarter 2021 Financial Results

GlobeNewswire May 5, 2021

Conformis Announces Achievement of Third Milestone Under Development and License Agreements

GlobeNewswire April 22, 2021

Conformis Announces License Agreement with Paragon 28

GlobeNewswire April 19, 2021

Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021

GlobeNewswire April 7, 2021

Clinical Study: Patient-Specific Total Knee Replacement with Conformis Technology Is More Cost-Effective Than with Leading Off-the-Shelf Implants

GlobeNewswire March 16, 2021

Conformis, Inc. Reports Fourth Quarter and Year End 2020 Financial Results

GlobeNewswire March 3, 2021

Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System

GlobeNewswire March 1, 2021

Conformis, Inc. to Participate in Upcoming Investor Conferences

GlobeNewswire February 25, 2021

Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock

GlobeNewswire February 12, 2021

Conformis, Inc. Announces Proposed Public Offering of Common Stock

GlobeNewswire February 11, 2021

Conformis, Inc. and SITES Medical Announce Development & Supply Agreement

GlobeNewswire January 21, 2021

Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 3, 2021

GlobeNewswire January 7, 2021

Conformis, Inc. to Participate in Upcoming Investor Conferences

GlobeNewswire December 31, 2020

Conformis Announces U.S. Commercial Launch of Cordera(TM) Match Hip System

GlobeNewswire December 17, 2020

Conformis, Inc. to Participate in the 32nd Annual Piper Sandler Healthcare Conference

GlobeNewswire November 24, 2020

Conformis Announces Bart Lagae as VP, International Sales & Marketing; Inducement Grant Reported

GlobeNewswire November 9, 2020